Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Polls archive

With the release of the Process, Promise, and Arise trials—which showed no benefit from early goal directed therapy (EGDT) compared to usual care—which of the following describes your approach to seps

  • I have omitted certain steps of the EGDT protocol. (59%)
  • No change, I wasn’t following EGDT anyway. (19%)
  • No change, I continue to support sepsis management with EGDT. (19%)
  • I have abandoned EGDT altogether. (3%)

Total Voters: 581

Start Date: June 4, 2015 @ 11:48 am

End Date: No Expiry

Are you in favor of legalization OR decriminalization of marijuana use?

  • Both legalization and decriminalization (49%)
  • Neither (24%)
  • Decriminalization (19%)
  • Legalization (8%)

Total Voters: 770

Start Date: December 18, 2014 @ 6:57 pm

End Date: June 4, 2015 @ 12:01 pm

What is your favorite part of the ACEP annual meeting?

  • Education sessions (40%)
  • Networking (33%)
  • Exhibit Hall (14%)
  • Celebrations (9%)
  • Keynote speakers (5%)

Total Voters: 68

Start Date: October 27, 2014 @ 2:16 pm

End Date: No Expiry

Who should be eligible to join ACEP?

  • ACEP should retain the current policy requiring board certification in emergency medicine for membership (50%)
  • ACEP should develop an additional membership category for physicians not board certified in emergency medicine (50%)

Total Voters: 729

Start Date: August 14, 2014 @ 2:00 pm

End Date: No Expiry

USA Today reported in October that hospitals “are starting to cut thousands of jobs amid falling insurance payments and inpatient visits.” Have you seen any evidence of this?

  • Yes (62%)
  • No (30%)
  • Not Sure (8%)

Total Voters: 927

Start Date: December 1, 2013 @ 12:00 am

End Date: October 27, 2014 @ 2:20 pm

 Page 2 of 3  «  1  2  3  » 

Current Issue

ACEP Now: November 2025

Download PDF

Read More

Polls

Which topic would you like to see ACEP Now tackle?

View Results

Loading ... Loading ...
  • Polls Archive
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603